{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:23:39Z","timestamp":1793413419477,"version":"4.5.0"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T00:00:00Z","timestamp":1533168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T00:00:00Z","timestamp":1533168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1038\/s41581-018-0044-0","type":"journal-article","created":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T07:31:06Z","timestamp":1533195066000},"page":"541-557","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":216,"title":["Intravenous fluid therapy in critically ill adults"],"prefix":"10.1038","volume":"14","author":[{"given":"Simon","family":"Finfer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Myburgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinaldo","family":"Bellomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,2]]},"reference":[{"key":"44_CR1","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/S0140-6736(89)92583-X","volume":"333","author":"JE Cosnett","year":"1989","unstructured":"Cosnett, J. E. The origins of intravenous fluid therapy. Lancet 333, 768\u2013771 (1989).","journal-title":"Lancet"},{"key":"44_CR2","first-page":"379","volume":"1832","author":"T Latta","year":"1832","unstructured":"Latta, T. Injections into the veins in cholera. London Med. Gaz. 1832, 379\u2013382 (1832).","journal-title":"London Med. Gaz."},{"key":"44_CR3","first-page":"274","volume":"2","author":"T Latta","year":"1832","unstructured":"Latta, T. Malignant cholera. Lancet 2, 274\u2013277 (1832).","journal-title":"Lancet"},{"key":"44_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0140-6736(02)82831-8","volume":"18","author":"R Lewins","year":"1832","unstructured":"Lewins, R. Injection of saline in extraordinary quantities into the veins in cases of malignant cholera. Lancet 18, 243\u2013244 (1832).","journal-title":"Lancet"},{"key":"44_CR5","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s00134-015-3850-x","volume":"41","author":"M Cecconi","year":"2015","unstructured":"Cecconi, M. et al. Fluid challenges in intensive care: the FENICE study: a global inception cohort study. Intensive Care Med. 41, 1529\u20131537 (2015).","journal-title":"Intensive Care Med."},{"key":"44_CR6","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/j.1365-2044.1981.tb08698.x","volume":"36","author":"JA Lee","year":"1981","unstructured":"Lee, J. A. Sydney Ringer (1834\u20131910) and Alexis Hartmann (1898\u20131964). Anaesthesia 36, 1115\u20131121 (1981).","journal-title":"Anaesthesia"},{"key":"44_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJMoa070716","volume":"358","author":"FM Brunkhorst","year":"2008","unstructured":"Brunkhorst, F. M. et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N. Engl. J. Med. 358, 125\u2013139 (2008).","journal-title":"N. Engl. J. Med."},{"key":"44_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1056\/NEJMoa1204242","volume":"367","author":"A Perner","year":"2012","unstructured":"Perner, A. et al. Hydroxyethyl starch 130\/0.42 versus Ringer\u2019s acetate in severe sepsis. N. Engl. J. Med. 367, 124\u2013134 (2012).","journal-title":"N. Engl. J. Med."},{"key":"44_CR9","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1056\/NEJMoa1209759","volume":"367","author":"JA Myburgh","year":"2012","unstructured":"Myburgh, J. A. et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N. Engl. J. Med. 367, 1901\u20131911 (2012).","journal-title":"N. Engl. J. Med."},{"key":"44_CR10","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0140-6736(00)04211-2","volume":"357","author":"F Schortgen","year":"2001","unstructured":"Schortgen, F. et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 357, 911\u2013916 (2001).","journal-title":"Lancet"},{"key":"44_CR11","first-page":"357","volume":"28","author":"K Landsteiner","year":"1900","unstructured":"Landsteiner, K. Zur Kentniss der antifermentativen lytischen und agglutinierenden Wirkungen des Blutserums und der Lymphe. Zentralbl. Bakt. 28, 357\u2013362 (1900).","journal-title":"Zentralbl. Bakt."},{"key":"44_CR12","unstructured":"Kendrick, D. B. Blood Program in World War II Ch. 1 (US Army Medical Department Office of Medical History, 1994)."},{"key":"44_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/cc9293","volume":"14","author":"S Finfer","year":"2010","unstructured":"Finfer, S. et al. Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units. Crit. Care 14, R185 (2010).","journal-title":"Crit. Care"},{"key":"44_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0176292","volume":"12","author":"NE Hammond","year":"2017","unstructured":"Hammond, N. E. et al. Patterns of intravenous fluid resuscitation use in adult intensive care patients between 2007 and 2014: an international cross-sectional study. PLoS ONE 12, e0176292 (2017).","journal-title":"PLoS ONE"},{"key":"44_CR15","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s00134-014-3576-1","volume":"41","author":"T Boulain","year":"2014","unstructured":"Boulain, T. et al. Volume expansion in the first 4 days of shock: a prospective multicentre study in 19 French intensive care units. Intensive Care Med. 41, 248\u2013256 (2014).","journal-title":"Intensive Care Med."},{"key":"44_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13741-016-0035-2","volume":"5","author":"TE Miller","year":"2016","unstructured":"Miller, T. E., Bunke, M., Nisbet, P. & Brudney, C. S. Fluid resuscitation practice patterns in intensive care units of the USA: a cross-sectional survey of critical care physicians. Perioper. Med. (Lond.) 5, 15 (2016).","journal-title":"Perioper. Med. (Lond.)"},{"key":"44_CR17","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1056\/NEJMra1208943","volume":"369","author":"JL Vincent","year":"2013","unstructured":"Vincent, J. L. & DeBacker, D. Circulatory shock. N. Engl. J. Med. 369, 1726\u20131734 (2013).","journal-title":"N. Engl. J. Med."},{"key":"44_CR18","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1056\/NEJMra1208627","volume":"369","author":"JA Myburgh","year":"2013","unstructured":"Myburgh, J. A. & Mythen, M. G. Resuscitation fluids. N. Engl. J. Med. 369, 1243\u20131251 (2013).","journal-title":"N. Engl. J. Med."},{"key":"44_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/CCM.0b013e3182772ab6","volume":"41","author":"DJ Funk","year":"2013","unstructured":"Funk, D. J., Jacobsohn, E. & Kumar, A. The role of venous return in critical illness and shock \u2014 part I: physiology. Crit. Care Med. 41, 255\u2013262 (2013).","journal-title":"Crit. Care Med."},{"key":"44_CR20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/CCM.0b013e31827bfc25","volume":"41","author":"DJ Funk","year":"2013","unstructured":"Funk, D. J., Jacobsohn, E. & Kumar, A. Role of the venous return in critical illness and shock: part II \u2014 shock and mechanical ventilation. Crit. Care Med. 41, 573\u2013579 (2013).","journal-title":"Crit. Care Med."},{"key":"44_CR21","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1097\/CCM.0b013e318260c6c3","volume":"40","author":"R Persichini","year":"2012","unstructured":"Persichini, R. et al. Effects of norepinephrine on mean systemic pressure and venous return in human septic shock. Crit. Care Med. 40, 3146\u20133153 (2012).","journal-title":"Crit. Care Med."},{"key":"44_CR22","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1097\/CCM.0b013e31826536db","volume":"40","author":"TW Scheeren","year":"2012","unstructured":"Scheeren, T. W. & Vos, J. J. Good old physiology in a modern jacket. Crit. Care Med. 40, 3309\u20133311 (2012).","journal-title":"Crit. Care Med."},{"key":"44_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-016-1401-7","volume":"20","author":"AS McLean","year":"2016","unstructured":"McLean, A. S. Echocardiography in shock management. Crit. Care 20, 275 (2016).","journal-title":"Crit. Care"},{"key":"44_CR24","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/bja\/aer515","volume":"108","author":"TE Woodcock","year":"2012","unstructured":"Woodcock, T. E. & Woodcock, T. M. Revised Starling equation and the glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy. Br. J. Anaesth. 108, 384\u2013394 (2012).","journal-title":"Br. J. Anaesth."},{"key":"44_CR25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1113\/jphysiol.1896.sp000596","volume":"19","author":"EH Starling","year":"1896","unstructured":"Starling, E. H. On the absorption of fluids from the connective tissue spaces. J. Physiol. 19, 312\u2013326 (1896).","journal-title":"J. Physiol."},{"key":"44_CR26","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/cvr\/cvq062","volume":"87","author":"JR Levick","year":"2010","unstructured":"Levick, J. R. & Michel, C. C. Microvascular fluid exchange and the revised Starling principle. Cardiovasc. Res. 87, 198\u2013210 (2010).","journal-title":"Cardiovasc. Res."},{"key":"44_CR27","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/cvr\/cvx023","volume":"113","author":"A Lukasz","year":"2017","unstructured":"Lukasz, A. et al. Endothelial glycocalyx breakdown is mediated by angiopoietin-2. Cardiovasc. Res. 113, 671\u2013680 (2017).","journal-title":"Cardiovasc. Res."},{"key":"44_CR28","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/cvr\/cvx044","volume":"113","author":"FE Curry","year":"2017","unstructured":"Curry, F. E. Layer upon layer: the functional consequences of disrupting the glycocalyx-endothelial barrier in vivo and in vitro. Cardiovasc. Res. 113, 559\u2013561 (2017).","journal-title":"Cardiovasc. Res."},{"key":"44_CR29","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nrneph.2015.162","volume":"11","author":"TJ Rabelink","year":"2015","unstructured":"Rabelink, T. J. & de Zeeuw, D. The glycocalyx \u2014 linking albuminuria with renal and cardiovascular disease. Nat. Rev. Nephrol. 11, 667\u2013676 (2015).","journal-title":"Nat. Rev. Nephrol."},{"key":"44_CR30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1098\/rstl.1861.0011","volume":"151","author":"TX Graham","year":"1861","unstructured":"Graham, T. X. Liquid diffusion applied to analysis. Phil. Trans. R. Soc. 151, 183\u2013224 (1861).","journal-title":"Phil. Trans. R. Soc."},{"key":"44_CR31","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/cc9052","volume":"14","author":"NaM Yunos","year":"2010","unstructured":"Yunos, N.a. M., Bellomo, R., Story, D. & Kellum, J. Bench-to-bedside review: chloride in critical illness. Crit. Care 14, 226\u2013226 (2010).","journal-title":"Crit. Care"},{"key":"44_CR32","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1172\/JCI110820","volume":"71","author":"CS Wilcox","year":"1983","unstructured":"Wilcox, C. S. Regulation of renal blood flow by plasma chloride. J. Clin. Invest. 71, 726\u2013735 (1983).","journal-title":"J. Clin. Invest."},{"key":"44_CR33","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1067\/mlc.2001.118176","volume":"138","author":"A Pedoto","year":"2001","unstructured":"Pedoto, A. et al. Role of nitric oxide in acidosis-induced intestinal injury in anesthetized rats. J. Lab. Clin. Med. 138, 270\u2013276 (2001).","journal-title":"J. Lab. Clin. Med."},{"key":"44_CR34","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1213\/00000539-199905000-00005","volume":"88","author":"TJ Gan","year":"1999","unstructured":"Gan, T. J. et al. Hextend, a physiologically balanced plasma expander for large volume use in major surgery: a randomized phase III clinical trial. Hextend Study Group. Anesth. Analg. 88, 992\u2013998 (1999).","journal-title":"Anesth. Analg."},{"key":"44_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1378\/chest.125.1.243","volume":"125","author":"JA Kellum","year":"2004","unstructured":"Kellum, J. A., Song, M. & Venkataraman, R. Effects of hyperchloremic acidosis on arterial pressure and circulating inflammatory molecules in experimental sepsis. Chest 125, 243\u2013248 (2004).","journal-title":"Chest"},{"key":"44_CR36","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/SLA.0b013e31825074f5","volume":"255","author":"AD Shaw","year":"2012","unstructured":"Shaw, A. D. et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann. Surg. 255, 821\u2013829 (2012).","journal-title":"Ann. Surg."},{"key":"44_CR37","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1001\/jama.2012.13356","volume":"308","author":"NM Yunos","year":"2012","unstructured":"Yunos, N. M. et al. Association between a chloride-liberal versus chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 308, 1566\u20131572 (2012).","journal-title":"JAMA"},{"key":"44_CR38","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000329229","volume":"174","author":"P Singh","year":"2011","unstructured":"Singh, P. & Okusa, M. D. The role of tubuloglomerular feedback in the pathogenesis of acute kidney injury. Contrib. Nephrol. 174, 12\u201321 (2011).","journal-title":"Contrib. Nephrol."},{"key":"44_CR39","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1001\/jama.2015.12334","volume":"314","author":"P Young","year":"2015","unstructured":"Young, P. et al. Effect of a buffered crystalloid solution versus saline on acute kidney injury among patients in the intensive care unit: the SPLIT randomized clinical trial. JAMA 314, 1701\u20131710 (2015).","journal-title":"JAMA"},{"key":"44_CR40","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJMoa1711586","volume":"378","author":"WH Self","year":"2018","unstructured":"Self, W. H. et al. Balanced crystalloids versus saline in noncritically ill adults. N. Engl. J. Med. 378, 819\u2013828 (2018).","journal-title":"N. Engl. J. Med."},{"key":"44_CR41","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1711584","volume":"378","author":"MW Semler","year":"2018","unstructured":"Semler, M. W. et al. Balanced crystalloids versus saline in critically ill adults. N. Engl. J. Med. 378, 829\u2013839 (2018).","journal-title":"N. Engl. J. Med."},{"key":"44_CR42","first-page":"CD004089","volume":"9","author":"S Bampoe","year":"2017","unstructured":"Bampoe, S. et al. Perioperative administration of buffered versus non-buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures. Cochrane Database Syst. Rev. 9, CD004089 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"key":"44_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e5752","volume":"345","author":"T Harris","year":"2012","unstructured":"Harris, T., Thomas, G. O. & Brohi, K. Early fluid resuscitation in severe trauma. BMJ 345, e5752 (2012).","journal-title":"BMJ"},{"key":"44_CR44","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1056\/NEJM199410273311701","volume":"331","author":"WH Bickell","year":"1994","unstructured":"Bickell, W. H. et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N. Engl. J. Med. 331, 1105\u20131109 (1994).","journal-title":"N. Engl. J. Med."},{"key":"44_CR45","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1056\/NEJMoa067514","volume":"357","author":"The SAFE Study Investigators","year":"2007","unstructured":"The SAFE Study Investigators et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N. Engl. J. Med. 357, 874\u2013884 (2007).","journal-title":"N. Engl. J. Med."},{"key":"44_CR46","first-page":"48","volume":"20","author":"N Iguchi","year":"2018","unstructured":"Iguchi, N. et al. Differential effects of isotonic and hypotonic 4% albumin solution on intracranial pressure and renal perfusion and function. Crit. Care Resusc. 20, 48\u201353 (2018).","journal-title":"Crit. Care Resusc."},{"key":"44_CR47","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1001\/jama.291.11.1350","volume":"291","author":"DJ Cooper","year":"2004","unstructured":"Cooper, D. J. et al. Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial. JAMA 291, 1350\u20131357 (2004).","journal-title":"JAMA"},{"key":"44_CR48","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/MCC.0b013e3283632d46","volume":"19","author":"TJ Morgan","year":"2013","unstructured":"Morgan, T. J. The ideal crystalloid \u2014 what is \u2018balanced\u2019? Curr. Opin. Crit. Care 19, 299\u2013307 (2013).","journal-title":"Curr. Opin. Crit. Care"},{"key":"44_CR49","doi-asserted-by":"crossref","unstructured":"Starling, E. H. Principles of Human Physiology (Lea & Febiger, 1912).","DOI":"10.1097\/00007611-191211000-00025"},{"key":"44_CR50","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1056\/NEJMoa040232","volume":"350","author":"S Finfer","year":"2004","unstructured":"Finfer, S. et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N. Engl. J. Med. 350, 2247\u20132256 (2004).","journal-title":"N. Engl. J. Med."},{"key":"44_CR51","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJMoa1305727","volume":"370","author":"P Caironi","year":"2014","unstructured":"Caironi, P. et al. Albumin replacement in patients with severe sepsis or septic shock. N. Engl. J. Med. 370, 1412\u20131421 (2014).","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 1","key":"44_CR52","first-page":"S115","volume":"37","author":"J Charpentier","year":"2011","unstructured":"Charpentier, J. & Mira, J. Efficacy and tolerance of hyperoncotic albumin administration in septic shock patients: the EARSS study [abstract]. Intensive Care Med. 37 (Suppl. 1), S115\u20130438 (2011).","journal-title":"Intensive Care Med."},{"key":"44_CR53","first-page":"547","volume":"60","author":"H Tomita","year":"1994","unstructured":"Tomita, H., Ito, U., Tone, O., Masaoka, H. & Tominaga, B. High colloid oncotic therapy for contusional brain edema. Acta Neurochir. Suppl. 60, 547\u2013549 (1994).","journal-title":"Acta Neurochir. Suppl."},{"key":"44_CR54","first-page":"259","volume":"7","author":"P Caironi","year":"2009","unstructured":"Caironi, P. & Gattinoni, L. The clinical use of albumin: the point of view of a specialist in intensive care. Blood Transfus. 7, 259\u2013267 (2009).","journal-title":"Blood Transfus."},{"key":"44_CR55","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1136\/bmj.38985.398704.7C","volume":"333","author":"The SAFE Study Investigators","year":"2006","unstructured":"The SAFE Study Investigators et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ 333, 1044\u20131046 (2006).","journal-title":"BMJ"},{"key":"44_CR56","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1089\/neu.2012.2573","volume":"30","author":"DJ Cooper","year":"2013","unstructured":"Cooper, D. J. et al. Albumin resuscitation for traumatic brain injury: is intracranial hypertension the cause of increased mortality? J. Neurotrauma 30, 512\u2013518 (2013).","journal-title":"J. Neurotrauma"},{"key":"44_CR57","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s00134-010-2081-4","volume":"37","author":"S Finfer","year":"2011","unstructured":"Finfer, S. et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med. 37, 86\u201396 (2011).","journal-title":"Intensive Care Med."},{"key":"44_CR58","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM199908053410603","volume":"341","author":"P Sort","year":"1999","unstructured":"Sort, P. et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N. Engl. J. Med. 341, 403\u2013409 (1999).","journal-title":"N. Engl. J. Med."},{"key":"44_CR59","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.jhep.2012.06.013","volume":"57","author":"M Guevara","year":"2012","unstructured":"Guevara, M. et al. Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study. J. Hepatol. 57, 759\u2013765 (2012).","journal-title":"J. Hepatol."},{"key":"44_CR60","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1097\/00003246-200210000-00001","volume":"30","author":"GS Martin","year":"2002","unstructured":"Martin, G. S. et al. Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury. Crit. Care Med. 30, 2175\u20132182 (2002).","journal-title":"Crit. Care Med."},{"key":"44_CR61","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1097\/01.CCM.0000171539.47006.02","volume":"33","author":"GS Martin","year":"2005","unstructured":"Martin, G. S. et al. A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit. Care Med. 33, 1681\u20131687 (2005).","journal-title":"Crit. Care Med."},{"key":"44_CR62","first-page":"CD007594","volume":"7","author":"TC Mutter","year":"2013","unstructured":"Mutter, T. C., Ruth, C. A. & Dart, A. B. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst. Rev. 7, CD007594 (2013).","journal-title":"Cochrane Database Syst. Rev."},{"key":"44_CR63","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00134-009-1704-0","volume":"36","author":"MA Schick","year":"2010","unstructured":"Schick, M. A. et al. The impact of crystalloid and colloid infusion on the kidney in rodent sepsis. Intensive Care Med. 36, 541\u2013548 (2010).","journal-title":"Intensive Care Med."},{"key":"44_CR64","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s00134-013-3156-9","volume":"40","author":"CJ Wiedermann","year":"2014","unstructured":"Wiedermann, C. J. & Joannidis, M. Accumulation of hydroxyethyl starch in human and animal tissues: a systematic review. Intensive Care Med. 40, 160\u2013170 (2014).","journal-title":"Intensive Care Med."},{"key":"44_CR65","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1001\/jama.2013.430","volume":"309","author":"R Zarychanski","year":"2013","unstructured":"Zarychanski, R. et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA 309, 678\u2013688 (2013).","journal-title":"JAMA"},{"key":"44_CR66","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/S0140-6736(96)07588-5","volume":"348","author":"ML Cittanova","year":"1996","unstructured":"Cittanova, M. L. et al. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 348, 1620\u20131622 (1996).","journal-title":"Lancet"},{"key":"44_CR67","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1001\/jama.2013.280502","volume":"310","author":"D Annane","year":"2013","unstructured":"Annane, D. et al. Effects of fluid resuscitation with colloids versus crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA 310, 1809\u20131817 (2013).","journal-title":"JAMA"},{"key":"44_CR68","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1007\/s00134-016-4278-7","volume":"43","author":"C Ertmer","year":"2017","unstructured":"Ertmer, C., Annane, D. & Van Der Linden, P. Is the literature inconclusive about the harm from HES? Yes. Intensive Care Med. 43, 1520\u20131522 (2017).","journal-title":"Intensive Care Med."},{"key":"44_CR69","unstructured":"European Medicines Agency. Hydroxyethyl-starch solutions (HES) should no longer be used in patients with sepsis or burn injuries or in critically ill patients. EMA http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/Solutions_for_infusion_containing_hydroxyethyl_starch\/European_Commission_final_decision\/WC500162361.pdf (2014)."},{"key":"44_CR70","unstructured":"US Food and Drug Administration. Vouluven (6% Hydroxyethyl starch 130\/0.4 in 0.9% sodium chloride injection), for administration by intravenous infusion. FDA https:\/\/www.fda.gov\/downloads\/biologicsbloodvaccines\/bloodbloodproducts\/approvedproducts\/newdrugapplicationsndas\/ucm083138.pdf (2007)."},{"key":"44_CR71","unstructured":"European Medicines Agency. Hydroxyethyl-starch solutions for infusion to be suspended \u2013 CMDh endorses PRAC recommendation: suspension due to serious risks of kidney injury and death in certain patient populations. EMA http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2018\/01\/news_detail_002892.jsp&mid=WC0b01ac058004d5c1 (2018)."},{"key":"44_CR72","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1097\/CCM.0b013e318258fee7","volume":"40","author":"O Bayer","year":"2012","unstructured":"Bayer, O. et al. Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: a prospective sequential analysis. Crit. Care Med. 40, 2543\u20132551 (2012).","journal-title":"Crit. Care Med."},{"key":"44_CR73","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jcrc.2016.04.011","volume":"35","author":"C Moeller","year":"2016","unstructured":"Moeller, C. et al. How safe is gelatin? A systematic review and meta-analysis of gelatin-containing plasma expanders versus crystalloids and albumin. J. Crit. Care 35, 75\u201383 (2016).","journal-title":"J. Crit. Care"},{"key":"44_CR74","first-page":"1107","volume":"82","author":"A Pisano","year":"2016","unstructured":"Pisano, A., Landoni, G. & Bellomo, R. The risk of infusing gelatin? Die-hard misconceptions and forgotten (or ignored) truths. Minerva Anestesiol. 82, 1107\u20131114 (2016).","journal-title":"Minerva Anestesiol."},{"key":"44_CR75","first-page":"CD000567","volume":"2","author":"P Perel","year":"2013","unstructured":"Perel, P., Roberts, I. & Ker, K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst. Rev. 2, CD000567 (2013).","journal-title":"Cochrane Database Syst. Rev."},{"key":"44_CR76","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000313760","volume":"165","author":"R Bellomo","year":"2010","unstructured":"Bellomo, R., Prowle, J., Echeverri, J., Ligabo, V. & Ronco, C. Fluid management in septic acute kidney injury and cardiorenal syndromes. Contrib. Nephrol. 165, 206\u2013218 (2010).","journal-title":"Contrib. Nephrol."},{"key":"44_CR77","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","volume":"52","author":"C Ronco","year":"2008","unstructured":"Ronco, C., Haapio, M., House, A., Anavekar, N. & Bellomo, R. Cardiorenal syndrome. J. Am. Coll. Cardiol. 52, 1527\u20131539 (2008).","journal-title":"J. Am. Coll. Cardiol."},{"key":"44_CR78","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1093\/ndt\/gfq066","volume":"25","author":"SM Bagshaw","year":"2010","unstructured":"Bagshaw, S. M. et al. Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI consensus conference. Nephrol. Dial. Transplant. 25, 1406\u20131416 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"44_CR79","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1093\/ndt\/gfq252","volume":"25","author":"A Davenport","year":"2010","unstructured":"Davenport, A. et al. ADQI 7: the clinical management of the cardio-renal syndromes: work group statements from the 7th ADQI consensus conference. Nephrol. Dial. Transplant. 25, 2077\u20132089 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"44_CR80","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jcrc.2017.07.030","volume":"42","author":"SM Bagshaw","year":"2017","unstructured":"Bagshaw, S. M. et al. The effect of low-dose furosemide in critically ill patients with early acute kidney injury: a pilot randomized blinded controlled trial (the SPARK study). J. Crit. Care 42, 138\u2013146 (2017).","journal-title":"J. Crit. Care"},{"key":"44_CR81","doi-asserted-by":"publisher","first-page":"966","DOI":"10.2215\/CJN.08781010","volume":"6","author":"ME Grams","year":"2011","unstructured":"Grams, M. E., Estrella, M. M., Coresh, J., Brower, R. G. & Liu, K. D. Fluid balance, diuretic use, and mortality in acute kidney injury. Clin. J. Am. Soc. Nephrol. 6, 966\u2013973 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"44_CR82","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1097\/CCM.0000000000003119","volume":"46","author":"MM Levy","year":"2018","unstructured":"Levy, M. M., Evans, L. E. & Rhodes, A. The surviving sepsis campaign bundle: 2018 update. Crit. Care Med. 46, 997\u20131000 (2018).","journal-title":"Crit. Care Med."},{"key":"44_CR83","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/SHK.0b013e31829727f1","volume":"40","author":"S Bihari","year":"2013","unstructured":"Bihari, S., Prakash, S. & Bersten, A. D. Post resusicitation fluid boluses in severe sepsis or septic shock: prevalence and efficacy (PRICE study). Shock 40, 28\u201334 (2013).","journal-title":"Shock"},{"key":"44_CR84","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jcrc.2016.05.017","volume":"35","author":"NJ Glassford","year":"2016","unstructured":"Glassford, N. J. et al. Defining the characteristics and expectations of fluid bolus therapy: a worldwide perspective. J. Crit. Care 35, 126\u2013132 (2016).","journal-title":"J. Crit. Care"},{"key":"44_CR85","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/SLA.0b013e318256be72","volume":"256","author":"AH Chowdhury","year":"2012","unstructured":"Chowdhury, A. H., Cox, E. F., Francis, S. T. & Lobo, D. N. A randomized, controlled, double-blind crossover study on the effects of 2-l infusions of 0.9% saline and Plasma-Lyte 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann. Surg. 256, 18\u201324 (2012).","journal-title":"Ann. Surg."},{"key":"44_CR86","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/CCM.0b013e3181feeb15","volume":"39","author":"JH Boyd","year":"2011","unstructured":"Boyd, J. H., Forbes, J., Nakada, T. A., Walley, K. R. & Russell, J. A. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit. Care Med. 39, 259\u2013265 (2011).","journal-title":"Crit. Care Med."},{"key":"44_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/cc13133","volume":"17","author":"M Legrand","year":"2013","unstructured":"Legrand, M. et al. Association between systemic hemodynamics and septic acute kidney injury in critically ill patients: a retrospective observational study. Crit. Care 17, R278 (2013).","journal-title":"Crit. Care"},{"key":"44_CR88","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1378\/chest.07-2331","volume":"134","author":"PE Marik","year":"2008","unstructured":"Marik, P. E., Baram, M. & Vahid, B. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest 134, 172\u2013178 (2008).","journal-title":"Chest"},{"key":"44_CR89","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.jcrc.2015.05.003","volume":"30","author":"BT Wong","year":"2015","unstructured":"Wong, B. T. et al. Mean arterial pressure and mean perfusion pressure deficit in septic acute kidney injury. J. Crit. Care 30, 975\u2013981 (2015).","journal-title":"J. Crit. Care"},{"key":"44_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s40635-014-0026-x","volume":"2","author":"P Cruces","year":"2014","unstructured":"Cruces, P. et al. The renal compartment: a hydraulic view. Intensive Care Med. Exp. 2, 26 (2014).","journal-title":"Intensive Care Med. Exp."},{"key":"44_CR91","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000313754","volume":"165","author":"MD Okusa","year":"2010","unstructured":"Okusa, M. D. The changing pattern of acute kidney injury: from one to multiple organ failure. Contrib. Nephrol. 165, 153\u2013158 (2010).","journal-title":"Contrib. Nephrol."},{"key":"44_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/cc13177","volume":"18","author":"G Virzi","year":"2014","unstructured":"Virzi, G., Day, S., de Cal, M., Vescovo, G. & Ronco, C. Heart\u2013kidney crosstalk and role of humoral signaling in critical illness. Crit. Care 18, 201 (2014).","journal-title":"Crit. Care"},{"key":"44_CR93","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s00134-016-4500-7","volume":"42","author":"PB Hjortrup","year":"2016","unstructured":"Hjortrup, P. B. et al. Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial. Intensive Care Med. 42, 1695\u20131705 (2016).","journal-title":"Intensive Care Med."},{"key":"44_CR94","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1056\/NEJMoa062200","volume":"354","author":"The National Heart Lung and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network","year":"2006","unstructured":"The National Heart Lung and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network et al. Comparison of two fluid-management strategies in acute lung injury. N. Engl. J. Med. 354, 2564\u20132575 (2006).","journal-title":"N. Engl. J. Med."},{"key":"44_CR95","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1056\/NEJMoa1701380","volume":"376","author":"PRISM Investigators","year":"2017","unstructured":"PRISM Investigators et al. Early goal-directed therapy for septic shock \u2014 a patient-level meta-analysis. N. Engl. J. Med. 376, 2223\u20132234 (2017).","journal-title":"N. Engl. J. Med."},{"key":"44_CR96","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1056\/NEJMoa1101549","volume":"364","author":"K Maitland","year":"2011","unstructured":"Maitland, K. et al. Mortality after fluid bolus in African children with severe infection. N. Engl. J. Med. 364, 2483\u20132495 (2011).","journal-title":"N. Engl. J. Med."},{"key":"44_CR97","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1001\/jama.2017.10913","volume":"318","author":"B Andrews","year":"2017","unstructured":"Andrews, B. et al. Effect of an early resuscitation protocol on in-hospital mortality among adults with sepsis and hypotension: a randomized clinical trial. JAMA 318, 1233\u20131240 (2017).","journal-title":"JAMA"},{"key":"44_CR98","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1001\/jama.294.7.813","volume":"294","author":"S Uchino","year":"2005","unstructured":"Uchino, S. et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294, 813\u2013818 (2005).","journal-title":"JAMA"},{"key":"44_CR99","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1056\/NEJMoa1801601","volume":"378","author":"PS Myles","year":"2018","unstructured":"Myles, P. S. et al. Restrictive versus liberal fluid therapy for major abdominal surgery. N. Engl. J. Med. 378, 2263\u20132274 (2018).","journal-title":"N. Engl. J. Med."},{"key":"44_CR100","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/MCC.0000000000000214","volume":"21","author":"J Martensson","year":"2015","unstructured":"Martensson, J. & Bellomo, R. Are all fluids bad for the kidney? Curr. Opin. Crit. Care 21, 292\u2013301 (2015).","journal-title":"Curr. Opin. Crit. Care"},{"key":"44_CR101","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/oxfordjournals.aje.a113261","volume":"114","author":"A Donner","year":"1981","unstructured":"Donner, A., Birkett, N. & Buck, C. Randomization by cluster. Sample size requirements and analysis. Am. J. Epidemiol. 114, 906\u2013914 (1981).","journal-title":"Am. J. Epidemiol."},{"key":"44_CR102","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/S0197-2456(03)00093-X","volume":"24","author":"LB Connelly","year":"2003","unstructured":"Connelly, L. B. Balancing the number and size of sites: an economic approach to the optimal design of cluster samples. Control. Clin. Trials 24, 544\u2013559 (2003).","journal-title":"Control. Clin. Trials"},{"key":"44_CR103","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-017-1923-6","volume":"18","author":"WH Self","year":"2017","unstructured":"Self, W. H. et al. Saline versus balanced crystalloids for intravenous fluid therapy in the emergency department: study protocol for a cluster-randomized, multiple-crossover trial. Trials 18, 178 (2017).","journal-title":"Trials"},{"key":"44_CR104","doi-asserted-by":"publisher","DOI":"10.1007\/s10916-017-0806-4","volume":"41","author":"AC McKown","year":"2017","unstructured":"McKown, A. C. et al. Predicting major adverse kidney events among critically ill adults using the electronic health record. J. Med. Syst. 41, 156 (2017).","journal-title":"J. Med. Syst."},{"key":"44_CR105","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1164\/rccm.201607-1345OC","volume":"195","author":"MW Semler","year":"2017","unstructured":"Semler, M. W. et al. Balanced crystalloids versus saline in the intensive care unit. The SALT randomized trial. Am. J. Respir. Crit. Care Med. 195, 1362\u20131372 (2017).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"44_CR106","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1007\/s00134-015-3822-1","volume":"41","author":"DC Angus","year":"2015","unstructured":"Angus, D. C. et al. A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators. Intensive Care Med. 41, 1549\u20131560 (2015).","journal-title":"Intensive Care Med."},{"key":"44_CR107","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1056\/NEJMoa010307","volume":"345","author":"E Rivers","year":"2001","unstructured":"Rivers, E. et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N. Engl. J. Med. 345, 1368\u20131377 (2001).","journal-title":"N. Engl. J. Med."},{"key":"44_CR108","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1056\/NEJMoa011300","volume":"345","author":"G van den Berghe","year":"2001","unstructured":"van den Berghe, G. et al. Intensive insulin therapy in critically ill patients. N. Engl. J. Med. 345, 1359\u20131367 (2001).","journal-title":"N. Engl. J. Med."},{"key":"44_CR109","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","volume":"360","author":"Investigators NICE-SUGAR Study","year":"2009","unstructured":"NICE-SUGAR Study Investigators et al. Intensive versus conventional glucose control in critically ill patients. N. Engl. J. Med. 360, 1283\u20131297 (2009).","journal-title":"N. Engl. J. Med."},{"key":"44_CR110","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1056\/NEJMe1800449","volume":"378","author":"J Myburgh","year":"2018","unstructured":"Myburgh, J. Patient-centered outcomes and resuscitation fluids. N. Engl. J. Med. 378, 862\u2013863 (2018).","journal-title":"N. Engl. J. Med."},{"key":"44_CR111","first-page":"175","volume":"19","author":"FG Zampieri","year":"2017","unstructured":"Zampieri, F. G. et al. Study protocol for the Balanced Solution Versus Saline in Intensive Care Study (BaSICS): a factorial randomised trial. Crit. Care Resusc. 19, 175\u2013182 (2017).","journal-title":"Crit. Care Resusc."},{"key":"44_CR112","first-page":"239","volume":"19","author":"NE Hammond","year":"2017","unstructured":"Hammond, N. E. et al. The Plasma-Lyte 148 v Saline (PLUS) study protocol: a multicentre, randomised controlled trial of the effect of intensive care fluid therapy on mortality. Crit. Care Resusc. 19, 239\u2013246 (2017).","journal-title":"Crit. Care Resusc."},{"key":"44_CR113","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41581-018-0008-4","volume":"14","author":"JA Kellum","year":"2018","unstructured":"Kellum, J. A. Abnormal saline and the history of intravenous fluids. Nat. Rev. Nephrol. 14, 358\u2013360 (2018).","journal-title":"Nat. Rev. Nephrol."},{"key":"44_CR114","doi-asserted-by":"publisher","first-page":"R204","DOI":"10.1186\/cc2872","volume":"8","author":"R Bellomo","year":"2004","unstructured":"Bellomo, R. et al. Acute renal failure \u2014 definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit. Care 8, R204\u2013R212 (2004).","journal-title":"Crit. Care"},{"key":"44_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.1","volume":"2","author":"Kidney Disease Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group","year":"2012","unstructured":"Kidney Disease Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int. Suppl. 2, 1\u2013138 (2012).","journal-title":"Kidney Int. Suppl."},{"key":"44_CR116","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1097\/CCM.0b013e318228234b","volume":"39","author":"KD Liu","year":"2011","unstructured":"Liu, K. D. et al. Acute kidney injury in patients with acute lung injury: impact of fluid accumulation on classification of acute kidney injury and associated outcomes. Crit. Care Med. 39, 2665\u20132671 (2011).","journal-title":"Crit. Care Med."},{"key":"44_CR117","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1053\/j.jvca.2015.02.004","volume":"29","author":"E Moore","year":"2015","unstructured":"Moore, E. et al. The impact of fluid balance on the detection, classification and outcome of acute kidney injury after cardiac surgery. J. Cardiothorac. Vasc. Anesth. 29, 1229\u20131235 (2015).","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"44_CR118","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1007\/s00134-013-3040-7","volume":"39","author":"NJ Glassford","year":"2013","unstructured":"Glassford, N. J. et al. The nature and discriminatory value of urinary neutrophil gelatinase-associated lipocalin in critically ill patients at risk of acute kidney injury. Intensive Care Med. 39, 1714\u20131724 (2013).","journal-title":"Intensive Care Med."},{"key":"44_CR119","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1001\/jama.2010.1546","volume":"304","author":"DC Angus","year":"2010","unstructured":"Angus, D. C. The lingering consequences of sepsis: a hidden public health disaster? JAMA 304, 1833\u20131834 (2010).","journal-title":"JAMA"},{"key":"44_CR120","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1001\/jama.2010.1553","volume":"304","author":"TJ Iwashyna","year":"2010","unstructured":"Iwashyna, T. J., Ely, E. W., Smith, D. M. & Langa, K. M. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 304, 1787\u20131794 (2010).","journal-title":"JAMA"},{"key":"44_CR121","first-page":"280","volume-title":"Trials","author":"PR Williamson","year":"2017","unstructured":"Williamson, P. R. et al. The COMET Handbook: version 1.0. Trials 18, 280 (2017)."}],"updated-by":[{"DOI":"10.1038\/s41581-018-0060-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T00:00:00Z","timestamp":1538611200000}}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-018-0044-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-018-0044-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-018-0044-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T17:37:13Z","timestamp":1733938633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-018-0044-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,2]]},"references-count":121,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["44"],"URL":"https:\/\/doi.org\/10.1038\/s41581-018-0044-0","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733756022.793550103","asserted-by":"object"}]},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,2]]},"assertion":[{"value":"2 August 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2018","order":2,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Corrections: Fig. 1: \u2018MAP\u2019 inserted before \u201860\u201365 mmHg; Fig. 3: \u2018Echocardiography\u2019 amended to \u2018Electrocardiographic\u2019. Fig. 4b additions: two cell nuclei; text labels \u2018Large pore transporting plasma proteins\u2019, \u2018Small pore network\u2019, \u2018Intercellular cleft\u2019; \u2018Intact\u2019 and \u2018Damaged\u2019; legend updated.","order":4,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.F., J.M. and R.B. declare that their employers have received research grants and travel reimbursement from Baxter Healthcare, CSL Bioplasma and Fresenius Kabi for the conduct of investigator-initiated clinical trials.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}